[{"id":"b74e36f6-cf32-4921-b6ad-d7fa7621e27e","acronym":"","url":"https://clinicaltrials.gov/study/NCT05395533","created_at":"2022-05-27T11:56:28.484Z","updated_at":"2024-07-02T16:35:31.809Z","phase":"Phase 1","brief_title":"A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.","source_id_and_acronym":"NCT05395533","lead_sponsor":"Zhejiang Teruisi Pharmaceutical Inc.","biomarkers":" CD20","pipe":" | ","alterations":" CD20 positive","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TRS005"],"overall_status":"Recruiting","enrollment":" Enrollment 152","initiation":"Initiation: 09/08/2020","start_date":" 09/08/2020","primary_txt":" Primary completion: 12/31/2023","primary_completion_date":" 12/31/2023","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2023-10-25"}]